Literature DB >> 16763589

Private biotech 2004--the numbers.

John Hodgson1.   

Abstract

Compared with the plethora of financial information about the publicly traded elite of the biotech world, little is known about the multitude of private biotech firms. Here, Nature Biotechnology's Editor-at-Large provides an analysis of the financial performance of the privately held biotech sector.

Mesh:

Year:  2006        PMID: 16763589     DOI: 10.1038/nbt0606-635

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  1 in total

1.  Laying the foundations for a bio-economy.

Authors:  Robert Carlson
Journal:  Syst Synth Biol       Date:  2008-02-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.